| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,627,000 | 1,432,000 | 1,354,000 | 1,599,000 | | Cost of Revenue | 1,297,000 | 1,202,000 | 1,194,000 | 1,384,000 | | | Gross Profit | 330,000 | 230,000 | 160,000 | 215,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 188,000 | 196,000 | 207,000 | 194,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 142,000 | 34,000 | (47,000) | 21,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 94,000 | 185,000 | 8,000 | 12,000 | | Earnings Before Interest And Taxes | 236,000 | 219,000 | (39,000) | 33,000 | | Interest Expense | 52,000 | 51,000 | 52,000 | 55,000 | | Income Before Tax | 184,000 | 168,000 | (91,000) | (22,000) | | Income Tax Expense | 56,000 | 43,000 | (12,000) | (6,000) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 128,000 | 125,000 | (79,000) | (16,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 128,000 | 125,000 | (79,000) | (16,000) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $128,000 | $125,000 | ($79,000) | ($16,000) |
|
0.16% Nasdaq 
Income Statement
